Navigation Links
Joseph J. Ross, M.D., F.A.C.S. Joins Stem Cell Assurance as Vice Chairman
Date:3/11/2010

BOCA RATON, Fla., March 11 /PRNewswire-FirstCall/ -- Stem Cell Assurance, Inc. (Pink Sheets: SCLZ) Stem Cell Assurance is pleased to announce the inclusion of one of the Cleveland Clinic's 2010 Best Doctors, Dr. Joseph J. Ross, M.D., F.A.C.S.  Dr. Ross will officially take up Vice Chairmanship for the company in March 2010.  Stem Cell Assurance welcomes his appointment to strengthen operations of their national physician network designed to provide medical and cosmetic procedures and cell banking to individual clients.  This latest development for Stem Cell Assurance follows the company's exponential growth in practice locations with the addition of many industry-leading physicians.    

Dr. Ross's experience makes him ideally placed to assume a central role within Stem Cell Assurance.  He currently holds professional positions at Envision Eye Specialists in Crystal River, Florida and The Omni Eye Institute in Ocala, Florida and is licensed in the states of Ohio, Arizona, and Florida.  He obtained his medical degree from Case Western Reserve University School of Medicine in Cleveland, Ohio and completed a fellowship in ophthalmic and facial cosmetic and reconstructive plastic surgery at the University of Arizona under renowned Preceptor Robert M. Dryden, M.D.  

Dr. Ross is board certified in ophthalmology.  He is a fellow of the American Academy of Facial Plastic Surgeons, the American Society of Ophthalmic Plastic and Reconstructive Surgeons, the American College of Surgeons, the Ohio State Medical Society, and the Florida Medical Association, among six other major memberships.  He is currently the Director of Oculoplastics Service at MetroHealth Medical Center in Cleveland, Ohio and Assistant Clinical Professor in the Department of Dermatology at Case Western Reserve University School of Medicine.    

Dr. Ross has authored publications on topics including cancer, facial contouring, dermal fat grafts, and facial implants.  His work has been included in major publications including The Journal of Dermatologic Surgery and Oncology and Ophthalmic Plastic and Reconstructive Surgery.  He has presented and lectured extensively on such topics as plastic, cosmetic, and reconstructive surgery techniques and office procedures; skin cancer detection and management; facelifts; nose reconstruction; skin care including products, chemical peels, microdermabrasion, and lasers; and micrografting.

As the new Vice Chairman of Stem Cell Assurance, Dr. Ross commented "Stem Cell Assurance, which offers invaluable bioinsurance services through stem cell banking and other exciting cosmetic applications, dovetails perfectly with my feelings towards the potential of stem cells to discover better therapies and ultimately even cures for debilitating diseases.  Stem Cell Assurance is ready to monetize its extensive assets and deliver its branded services to clients and patients.  I am eager to come aboard as Vice Chairman at this time of great growth in the company, and I look forward to the road ahead."

About Stem Cell Assurance

Stem Cell Assurance, Inc. is the first company in the US to provide full-spectrum adult stem cell services to consumers through a national physician network.  The company offers genetic profiling services and consultation, adult stem cell research, and stem cell collection, processing, and cryogenic storage, as well as cosmetic and other infusion therapies.  The company is based in Boca Raton, Florida.  See www.stemcellassurance.com for more information.

Investor Relations:

Equiti-Trend Advisors

800-953-3350

SOURCE Stem Cell Assurance, Inc.

Back to top

RELATED LINKS
http://www.stemcellassurance.com

'/>"/>

SOURCE Stem Cell Assurance, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
2. SGX Pharmaceuticals Appoints Joseph L. Turner to Board of Directors
3. Dr. Joseph L. Corriveau Appointed Director of Research and Technology
4. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
5. Joseph B. Bolen, Ph.D. from Millennium to Conference Chair Cancer Sessions at IBCs Drug Discovery & Development of Innovative Therapeutics Conference
6. Spherics, Inc. Assigns Assets to Joseph F. Finn, Jr., C.P.A.
7. WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility
8. St. Josephs Hospital and InNexus Biotechnology Enter Collaborative Partnership
9. Board of Directors of Milestone Scientific Names Joseph DAgostino Chief Financial Officer
10. St. Josephs Hospital and Medical Center to Utilize Clinical InfoNET System for Physicians
11. PAREXEL Appoints Josephine Hoppe to Chief Information Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... , ... The Pittcon Organizing Committee is pleased to announce that Charles “Chuck” ... of Committee since 1987. Since then, he has served in a number of key ... for both the program and exposition committees. In his professional career, Dr. Gardner is ...
(Date:4/27/2016)... ... April 27, 2016 , ... The Board of Directors ... of John Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven from Alexion ... commercial leaders responsible for the commercialization of multiple orphan drug indications. Mr. ...
(Date:4/27/2016)... ... ... Global Stem Cells Group CEO Benito Novas announced that Duncan Ross, Ph.D. ... Labs in Miami. , In 2004, Ross received his Ph.D. in Immunology from the ... the suppression of graft vs. host disease (GVHD) under UM Professor Robert Levy Ph.D. ...
(Date:4/26/2016)... ... April 27, 2016 , ... ... Christie LLP as an associate in the firm’s Intellectual Property practice group. , ... and electromechanical patent applications. He has an electrical engineering and computer engineering background, ...
Breaking Biology Technology:
(Date:3/11/2016)... Germany , March 11, 2016 http://www.apimages.com ... - Cross reference: Picture is available at AP Images ( http://www.apimages.com ... from DERMALOG will be used to produce the new refugee identity ... other biometric innovations, at CeBIT in Hanover ... scanner from DERMALOG will be used to produce the new refugee ...
(Date:3/9/2016)... , March 9, 2016 This BCC ... future states of the RNA Sequencing (RNA Seq) market ... such as instruments, tools and reagents, data analysis, and ... various segments of the RNA-Sequencing market such as RNA-Sequencing ... Identify the main factors affecting each segment and forecast ...
(Date:3/3/2016)... , March 3, 2016  FlexTech, a SEMI ... categories of Innovation, Research & Development, Leadership in Education, ... This is the 9 th year of the ... of companies and individuals from past years . ... on a pre-described set of criteria, by a panel ...
Breaking Biology News(10 mins):